Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Pathology
|
January 19, 2018
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
Jessica McAlpine, Alicia Leon-Castillo, Tjalling Bosse
Histopathology
|
April 9, 2021
Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer
Lisa Vermij, Naveena Singh, Alicia Leon-Castillo, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
July 30, 2024
Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study
Esther Lems, Anna H Koch, Sam Armbrust, et al.
Journal of Cutaneous Pathology
|
May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series
Alicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
May 28, 2025
Clinicopathological and Molecular Characterization of High Grade Endometrial Carcinomas of No Specific Molecular Profile (NSMP) Stratified by ER Status
Patrick Thaddeus Timmermans, Alicia Leon-Castillo, Claire Kramer, et al.
Cancers
|
December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
Lisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Gynecologic Oncology
|
January 26, 2022
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia Leon-Castillo, Nanda Horeweg, Elke E M Peters, et al.
JCO Global Oncology
|
May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
Obstetrical & Gynecological Survey
|
December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology
|
September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Pathology
|
January 19, 2018
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
Jessica McAlpine, Alicia Leon-Castillo, Tjalling Bosse
Histopathology
|
April 9, 2021
Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer
Lisa Vermij, Naveena Singh, Alicia Leon-Castillo, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
July 30, 2024
Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study
Esther Lems, Anna H Koch, Sam Armbrust, et al.
Journal of Cutaneous Pathology
|
May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series
Alicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
May 28, 2025
Clinicopathological and Molecular Characterization of High Grade Endometrial Carcinomas of No Specific Molecular Profile (NSMP) Stratified by ER Status
Patrick Thaddeus Timmermans, Alicia Leon-Castillo, Claire Kramer, et al.
Cancers
|
December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
Lisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Gynecologic Oncology
|
January 26, 2022
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia Leon-Castillo, Nanda Horeweg, Elke E M Peters, et al.
JCO Global Oncology
|
May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
Obstetrical & Gynecological Survey
|
December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Oncology
|
September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 1